Revenue Breakdown
Composition ()
No data
Revenue Streams
Viatris Inc (VTRS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Brands, accounting for 65.0% of total sales, equivalent to $2.44B. Another important revenue stream is Generics. Understanding this composition is critical for investors evaluating how VTRS navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, Viatris Inc maintains a gross margin of 39.84%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 11.39%, while the net margin is -3.41%. These profitability ratios, combined with a Return on Equity (ROE) of -21.09%, provide a clear picture of how effectively VTRS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, VTRS competes directly with industry leaders such as RGC and ROIV. With a market capitalization of $15.05B, it holds a significant position in the sector. When comparing efficiency, VTRS's gross margin of 39.84% stands against RGC's N/A and ROIV's 92.93%. Such benchmarking helps identify whether Viatris Inc is trading at a premium or discount relative to its financial performance.
